These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11435065)

  • 1. Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer.
    Oka M; Fukuda M; Fukuda M; Kinoshita A; Kuba M; Ichiki M; Rikimaru T; Soda H; Takatani H; Narasaki F; Nagashima S; Nakamura Y; Hayashi N; Kohno S
    Eur J Cancer; 2001 Jul; 37(11):1359-65. PubMed ID: 11435065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer.
    Oka M; Fukuda M; Kuba M; Ichiki M; Rikimaru T; Soda H; Tsurutani J; Nakamura Y; Kawabata S; Nakatomi K; Narasaki F; Nagashima S; Takatani H; Fukuda M; Kinoshita A; Kohno S
    Eur J Cancer; 2002 Oct; 38(15):1998-2004. PubMed ID: 12376204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].
    Yokoyama A; Kurita Y; Saijo N; Tamura T; Noda K; Shimokata K; Matsuda T
    Br J Cancer; 1998 Jul; 78(2):257-62. PubMed ID: 9683303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
    Fukuda M; Soda H; Fukuda M; Kinoshita A; Nakamura Y; Nagashima S; Takatani H; Tsukamoto K; Kohno S; Oka M
    Cancer; 2007 Aug; 110(3):606-13. PubMed ID: 17577234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
    Takeda K; Negoro S; Tanaka M; Fukuda H; Nakagawa K; Kawahara M; Semba H; Kudoh S; Sawa T; Saijo N; Fukuoka M
    Jpn J Clin Oncol; 2011 Jan; 41(1):25-31. PubMed ID: 20802006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
    J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Iwasaki Y; Ohsugi S; Natsuhara A; Tsubokura T; Harada H; Ueda M; Arimoto T; Hara H; Yamada T; Takesako T; Kohno K; Hosogi S; Nakanishi M; Marunaka Y; Nishimura T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):735-41. PubMed ID: 16565832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.
    Fukuda M; Nakamura Y; Kinoshita A; Soejima Y; Yamaguchi H; Ikeda T; Izumikawa K; Takatani H; Fukuda M; Soda H; Hayashi N; Tsukamoto K; Oka M; Kohno S
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):645-51. PubMed ID: 23010852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: a phase I study.
    de Jong WK; de Jonge MJ; van der Leest AH; van Meerbeeck JP; Groen HJ
    Lung Cancer; 2008 Jul; 61(1):123-8. PubMed ID: 18179842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma.
    Takiguchi Y; Uruma R; Asaka-Amano Y; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Uno T; Itoh H; Kuriyama T
    Int J Clin Oncol; 2005 Dec; 10(6):418-24. PubMed ID: 16369746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
    Oshita F; Yamada K; Kato Y; Ikehara M; Noda K; Tanaka G; Nomura I; Suzuki R; Saito H
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
    Masuda N; Fukuoka M; Fujita A; Kurita Y; Tsuchiya S; Nagao K; Negoro S; Nishikawa H; Katakami N; Nakagawa K; Niitani H
    Br J Cancer; 1998 Jul; 78(2):251-6. PubMed ID: 9683302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Takeda K; Negoro S; Kudoh S; Okishio K; Masuda N; Takada M; Tanaka M; Nakajima T; Tada T; Fukuoka M
    Br J Cancer; 1999 Mar; 79(9-10):1462-7. PubMed ID: 10188891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study.
    Ueoka H; Tabata M; Kiura K; Shibayama T; Gemba K; Segawa Y; Chikamori K; Yonei T; Hiraki S; Harada M
    Br J Cancer; 1999 Feb; 79(5-6):984-90. PubMed ID: 10070901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.
    Negoro S; Masuda N; Takada Y; Sugiura T; Kudoh S; Katakami N; Ariyoshi Y; Ohashi Y; Niitani H; Fukuoka M;
    Br J Cancer; 2003 Feb; 88(3):335-41. PubMed ID: 12569373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.
    Kobayashi M; Matsui K; Hirashima T; Nitta T; Sasada S; Tada T; Minakuchi K; Furukawa M; Ogata Y; Kawase I
    Int J Clin Oncol; 2006 Aug; 11(4):314-9. PubMed ID: 16937306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
    Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
    Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: dose-escalation phase I trial.
    Krzakowski M; Lucas C; Gridelli C
    Clin Lung Cancer; 2014 Jul; 15(4):266-73. PubMed ID: 24954229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer.
    Kasai T; Oka M; Soda H; Tsurutani J; Fukuda M; Nakamura Y; Kawabata S; Nakatomi K; Nagashima S; Takatani H; Fukuda M; Kinoshita A; Kohno S
    Eur J Cancer; 2002 Sep; 38(14):1871-8. PubMed ID: 12204669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.